The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice
Author(s) -
Muzaffar Abbas,
Sami I. Alzarea,
Roger L. Papke,
Shafiqur Rahman
Publication year - 2019
Publication title -
pharmacological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.706
H-Index - 83
eISSN - 2299-5684
pISSN - 1734-1140
DOI - 10.1016/j.pharep.2019.07.001
Subject(s) - allosteric modulator , allosteric regulation , nicotinic agonist , pharmacology , chemistry , acetylcholine receptor , nicotinic acetylcholine receptor , neuroscience , hippocampus , receptor , medicine , psychology , biochemistry
Previous studies have shown that α7 nicotinic acetylcholine receptor (nAChR) has a critical role in the regulation of pain sensitivity and neuroinflammation. However, pharmacological effects of α7 nAChR activation in the hippocampus on neuroinflammatory mechanisms associated with allodynia and hyperalgesia remain unknown. We have determined the effects of 3a,4,5,9b-tetrahydro-4-(1-naphthalenyl)-3H-cyclopentan[c]quinoline-8-sulfonamide (TQS), an α7 nAChR positive allosteric modulator, on lipopolysaccharide (LPS)-induced allodynia and hyperalgesia in mice. We also evaluated the effects of TQS on immunoreactivity of microglial marker ionized-calcium binding adaptor molecule 1 (Iba-1), phospho-nuclear factor-κB (p-NF-κB p 65 ), tumor necrosis factor-alpha (TNF-α), and norepinephrine (NE) level.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom